Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-18T10:58:28.348Z Has data issue: false hasContentIssue false

Sustained attention and executive functions in euthymic young people with bipolar disorder

Published online by Cambridge University Press:  02 January 2018

U. S. Kolur
Affiliation:
Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
Y. C. J. Reddy*
Affiliation:
Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
J. P. John
Affiliation:
Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
T. Kandavel
Affiliation:
Department of Biostatistics, National Institute of Mental Health and Neurosciences, Bangalore, India
S. Jain
Affiliation:
Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
*
Dr Y. C. Janardhan Reddy, Department of Psychiatry, NIMHANS, Bangalore 560029, India. Tel: +91 80 2699 5278; fax: +91 80 2656 4822; email: ycjreddy@yahoo.com, ycjreddy@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Background

Persistent neuropsychological impairments have been reported in the euthymic phase of bipolar affective disorder. However, the findings have been confounded by multiple episodes, chronic illness and residual mood symptoms.

Aims

To assess sustained attention and executive functioning in euthymic young people with bipolar I disorder who had had no more than two affective episodes.

Method

Thirty euthymic patients (with illness duration of less than 5 years and no more than two affective episodes) and 30 matched healthy individuals were assessed for sustained attention and executive functioning.

Results

The bipolar group (mean age 22.4 years, s.d.=2.52; duration of illness 20.87 months, s.d.=14.72), showed impairment on tasks of attention and executive functioning. Multivariate logistic regression analysis demonstrated that deficits in executive functioning differentiated cases from controls. There was no correlation between residual depressive symptoms and neuropsychological performance.

Conclusions

Deficits in attention and executive functioning were present in young people who had experienced only a few episodes of bipolar disorder, suggesting that the deficits are possibly trait abnormalities. Whether these deficits worsen with progression of illness needs to be examined in longitudinal studies.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2006 

Persistent neuropsychological deficits present in the euthymic state of bipolar affective disorder, particularly impairment in sustained attention, suggest that such deficits could be vulnerability trait markers of the illness (Clark et al, Reference Clark, Iversen and Goodwin2002, Reference Clark, Kempton and Scarna2005a ; Reference Clark and GoodwinClark & Goodwin, 2004; Reference Thompson, Gallagher and HughesThompson et al, 2005). However, previous studies included older participants with chronic illness and multiple episodes. It is demonstrated that the deficits correlate with both the duration of illness and the number of affective episodes (Reference McKay, Tarbuck and ShapleskeMcKay et al, 1995; Reference Denicoff, Ali and MirskyDenicoff et al, 1999; Reference Clark, Iversen and GoodwinClark et al, 2002; Reference Savitz, Solms and RamesarSavitz et al, 2005). Our study examined attention and executive functions in young euthymic patients with fewer episodes (maximum two) and shorter duration of illness (<5 years) to confirm that the deficits are not necessarily the result of chronicity of illness and multiple affective episodes. We predicted that attention and executive function deficits would be demonstrable in young people with bipolar disorder in the euthymic state compared with matched healthy controls.

METHOD

The study was conducted in compliance with the guidelines of the ethics committee of the institute, and all participants gave written informed consent.

Sample

Thirty persons who fulfilled the inclusion criteria were recruited into the study from the out-patient services of the National Institute of Mental Health and Neurosciences, Bangalore, India, during the period September 2003 to February 2005. None of them withdrew from the study. The inclusion criteria were a DSM–IV diagnosis of bipolar I disorder (American Psychiatric Association, 1994); illness duration of less than 5 years; a history of no more than two affective episodes; age below 30 years; right-handedness; at least 7 years of formal education; and euthymic state. Euthymic status was defined as a score of less than 6 on the Young Mania Rating Scale (YMRS; Reference Young, Biggs and ZieglerYoung et al, 1978) as well as on the 17-item Hamilton Rating Scale for Depression (HRSD; Reference HamiltonHamilton, 1960). Participants had to be free from active symptoms for at least 8 weeks preceding the assessment and did not fulfil DSM criteria for an affective episode. This was established by obtaining information from the patient, a close relative of the patient, and the clinical charts. Exclusion criteria included a Mini-Mental State Examination (MMSE; Reference Folstein, Folstein and McHughFolstein et al, 1975) score below 25; presence of any other comorbid Axis I disorder including lifetime alcohol and substance misuse; evidence of organic brain disorder or neurological disorder; history of treatment with electro-convulsive therapy; and presence of colour blindness and any auditory or visual impairment.

Control group

Thirty healthy individuals, individually matched with participating patients for age (±2 years), gender and years of education (±2 years), were recruited by word of mouth. They did not have any lifetime Axis I disorder, had had at least 7 years of formal education and were right-handed. Controls conformed to the same exclusion criteria as the participants with bipolar disorder. They also had no family history of major psychiatric illness (psychosis, affective disorder, suicide or alcohol and substance misuse) in a first-degree relative. This was confirmed by unstructured clinical interview of those recruited.

Clinical assessment

A diagnosis of bipolar disorder was established from several sources – clinical charts and unstructured clinical interviews of the participants and their immediate family members – and confirmed by administration of the Operational Criteria for Research (OPCRIT; Reference McGuffin, Farmer and HarveyMcGuffin et al, 1991; Reference Williams, Farmer and ArchenneilWilliams et al, 1996) and the Mini International Neuropsychiatric Interview (MINI; Reference Sheehan, Lecrubier and SheehanSheehan et al, 1998). Global functioning was assessed using the Global Assessment of Functioning (GAF; American Psychiatric Association, 1994). Members of the control group also completed the MINI to rule out the presence of any Axis I psychiatric disorder. Handedness was determined with the 10-item Edinburgh Handedness Inventory (Reference OldfieldOldfield, 1971) and colour blindness was ruled out using the Ishihara isochromatic charts. Demographic and clinical characteristics of the participants are shown in Table 1. At the time of assessment, 19 participants (63%) were taking an anti-psychotic drug (olanzapine 8, risperidone 6, chlorpromazine 5); 27 (90%) were taking a mood stabiliser (lithium 23, carbamazepine 2, valproate 2); 1 (3%) was taking an antidepressant; and 9 (30%) were taking trihexyphenidyl. Sixteen patients (53%) were receiving a combination of a mood stabiliser and other drugs and the remaining 14 (47%) were receiving monotherapy with either a mood stabiliser or an antipsychotic.

Table 1 Demographic and clinical characteristics of the sample

Variable Bipolar group (n=30) Control group (n=30) P
Gender, n (%)
    Male 21 (70) 21 (70)
    Female 9 (30) 9 (30)
Age, years: mean (s.d.)1 22.40 (2.52) 22.50 (2.32) 0.81
Years of education: mean (s.d.) 11.57 (1.94) 11.50 (1.85) 0.41
Marital status, n (%)
    Single 24 (80) 28 (93) 0.22
    Married 6 (20) 2 (7)
Religion, n (%)
    Hindu 26 (87) 28 (93) 0.69
    Muslim 2 (7) 1 (3)
    Christian 2 (7) 1 (3)
Occupation, n (%)
    Self-employed 4 (13) 0 0.04
    Unemployed 13 (43) 9 (30)
    Private job 5 (17) 14 (47)
    Government job 1 (3) 0
    Home-maker 7 (23) 7 (23)
Background, n (%)
    Urban 8 (27) 14 (47) 0.24
    Rural 22 (73) 16 (53)
Age at illness onset, years: mean (s.d.) 20.7 (2.53)
Duration of illness, months: mean (s.d.)2 20.87 (14.72)
Number of episodes, n (%)
    Single episode 13 (43)
    Two episodes 17 (57)
Time spent in episodes, weeks: mean (s.d.) 18.70 (11.15)
History of psychotic symptoms, n (%) 25 (83)
History of hospitalisation, n (%) 19 (63)
Number of admissions: mean (s.d.) 0.77 (0.68)
Duration of euthymia, weeks: mean (s.d.)3 40.80 (38.50)
Mood rating score: mean (s.d.)
    HRSD4 0.53 (0.77) 0 0.001
    YMRS 0 0
GAF score: mean (s.d.) 84.83 (5.49)
Family history of bipolar disorder, n (%) 10 (33)

Neuropsychological assessment

Neuropsychological assessment lasted from 1 h 15 min to 2 h. Assessments were performed in a fixed order in a quiet room by a trained psychiatrist (U.S.K.). If needed, a short break halfway through the assessment was permitted. The tests administered included the following: the Continuous Performance Test (Reference Cornblatt, Risch and FarisCornblatt et al, 1988) for sustained attention and executive function; the Trail Making Test (Reference Reitan and WolfsonReitan & Wolfson, 1985) part A for attention and psychomotor speed and part B for attention, psychomotor speed and executive function; the Wisconsin Card Sorting Test (Reference Heaton, Chelune and TalleyHeaton et al, 1993) for cognitive flexibility, working memory, problem-solving and set-shifting abilities; the Stroop colour–word association test for selective attention and executive function (Reference Comalli, Wapner and WernerComalli et al, 1962); and the Tower of London test for forward planning and working memory (Reference ShalliceShallice, 1982). These are well-established tests and detailed descriptions of them are found in standard texts (Reference LezakLezak, 1995; Reference Spreen and StraussSpreen & Strauss, 1998). The Tower of London test (Reference Rao, Subbakrishna and GopukumarRao et al, 2004) and the Trail Making Test (Reference MukundanMukundan, 1996) have been validated in the Indian population. The remaining tests are routinely used in the institute for clinical and research purposes. The tests were administered in the Kannada language to 12 participants in the bipolar group and 7 in the control group, and in English to the remaining participants.

Statistical analysis

The data were tested for normal distribution using the Shapiro–Wilk test. Since most of the neuropsychological variables were not normally distributed, non-parametric analysis was carried out. As the patients and controls were individually matched, between-group comparisons were made using the Wilcoxon signed rank test for continuous variables along with effect size for log-transformed values for matched pair design. Effect size (d) is given by d=my/sy, where my is the mean of the differences and sy the standard deviation of the differences (Reference CohenCohen, 1988). Categorical variables were analysed by McNemar's test for dependent samples. Subgroup analyses among patients were performed using the Mann–Whitney U-test.

Spearman's correlation analysis was employed to examine the relationship between the scores on neuropsychological tests and certain illness-related clinical variables and the HRSD score. To identify significant neuropsychological variables in differentiating cases and controls, the forward conditional logistic regression for matched case–control design was used (Reference Dunlop, Cortina and VaslowDunlop et al, 1996). Even though non-parametric tests were used, for clarity the data were expressed as mean and standard deviation for continuous variables and number and proportion for categorical variables. Statistical analysis was carried out using Stata version 7.0 for Windows, and all reported P values are two-tailed. All results at P<0.05 were considered to be significant.

RESULTS

The two study groups were comparable on most demographic variables (Table 1). Neuropsychological performance in the two groups is shown in Table 2. The results suggest that the participants with bipolar disorder had impaired sustained attention and executive functioning. Because of the large effect sizes on some of the variables, we performed further subgroup analyses in the patient group. Neuropsychological performance did not differ significantly between subgroups based on number of episodes (single episode, n=13 v. two episodes n=17), and presence (n=10) or absence (n=20) of family history of bipolar disorder except on the Continuous Performance Test commission errors (Z=–2.682, P=0.007 for number of episodes; Z=–2.154, P=0.031 for family history). There was also no significant difference based on other subgroupings such as gender, and intensity of current treatment (combination of a mood stabiliser and other drugs v. monotherapy).

Table 2 Neuropsychological performance

Measure Bipolar group (n=30) Mean (s.d.)1 Control group (n=30) Mean (s.d.)1 Z P Effect size2
Continuous Performance Test
    Total correct responses 29.63 (8.77) 39.20 (4.79) -4.076 <0.001 0.79
    Total commission errors 21.40 (29.91) 12.73 (7.15) 0.936 0.349 0.21
    Total omission errors 17.33 (8.74) 7.80 (4.79) 4.097 <0.001 0.99
    Response time, s 0.80 (0.20) 0.60 (0.20) 3.209 0.001 0.33
Trail Making Test
    Part A time, s 68.60 (20.67) 44.53 (15.69) 3.785 <0.001 0.86
    Part B time, s 129.47 (40.20) 68.07 (19.97) 4.639 <0.001 1.72
Stroop test
    Colour card time, s 110.53 (29.71) 72.60 (12.27) 4.701 <0.001 1.35
    Word card time, s 69.77 (17.14) 50.30 (7.67) 4.361 <0.001 1.07
    Interference time, s 168.77 (39.36) 113.70 (14.04) 4.454 <0.001 1.30
Wisconsin Card Sorting Test
    Categories 2.10 (1.30) 5.40 (1.25) -4.706 <0.001 1.69
    Perseverative errors 30.30 (10.40) 13.67 (5.99) 4.456 <0.001 1.32
Tower of London test
    Problems solved in minimum number of moves 8.90 (1.54) 10.00 (0.79) -3.138 0.001 0.68
    Four-move problems 6.58 (2.42) 5.39 (1.03) 2.511 0.012 0.44
    Five-move problems 8.25 (1.94) 6.37 (0.76) 4.077 <0.001 1.03

In the multivariate analysis, scores on the Stroop test (interference) (coefficient 0.074, s.e.=0.034, Z=2.14, P=0.033) and Tower London of minimum moves (coefficient –1.982, s.e.=1.122, Z=–1.77, P=0.077) differentiated cases from controls after controlling for the possible confounding effects of years of education, residual depressive symptoms (HRSD score) and urban/rural residence. The two variables accounted for 81% of the variance (R 2=0.8172).

To examine the effect of residual depressive symptoms on neuropsychological performance in the patient group, the HRSD score was correlated with all the neuropsychological variables. No significant correlation was found. However, years of education correlated with the Continuous Performance Test total correct responses (r=0.475, P<0.001) and omission errors (r=–0.485, P<0.001) and the time taken for the Stroop word card (r=–0.563, P<0.001). Average response time in the Continuous Performance Test and time taken for the Stroop colour and interference cards correlated with the time spent in affective episodes (Table 3). The number of episodes correlated with Continuous Performance Test commission errors. Global functioning measured by the GAF correlated with the Trail Making Test part A and Stroop colour card times.

Table 3 Correlation (Spearmans's rho) of illness characteristics and neurocognitive performance in patients with bipolar disorder.

Measure Age at onset Duration of illness Current euthymia Number of episodes Time spent in episodes Number of admissions GAF score
Continuous Performance Test
    Correct responses 0.287 0.005 0.299 -0.058 -0.275 0.110 -0.064
    Commission errors 0.088 -0.120 -0.121 0.498** 0.114 -0.014 0.016
    Omission errors -0.290 -0.005 -0.286 0.062 0.283 -0.113 0.057
    Average response time, s 0.081 0.055 -0.197 -0.109 0.462* -0.093 -0.041
Trail Making Test
    Part A time, s 0.071 0.068 -0.172 -0.226 0.078 -0.058 -0.388*
    Part B time, s 0.096 -0.062 -0.056 0.101 0.236 -0.349 -0.094
Stroop Test
    Colour card time, s -0.122 -0.025 -0.019 0.187 0.414* 0.136 -0.390*
    Word card time, s -0.123 -0.024 -0.031 0.292 0.159 -0.148 -0.207
    Interference time, s 0.061 -0.149 -0.115 0.284 0.516** -0.162 -0.225
Wisconsin Card Sorting Test
    Categories completed -0.103 0.194 0.064 -0.074 -0.152 0.031 0.150
    Perseverative errors, % -0.230 -0.009 -0.045 0.062 -0.293 0.002 0.152
Tower of London test
    Problems solved in minimum number of moves 0.008 0.055 0.063 -0.088 -0.258 0.058 0.029
    Four-move problems -0.230 -0.134 -0.212 0.254 0.125 -0.107 -0.163
    Five-move problems -0.012 -0.179 -0.004 0.078 0.047 0.012 0.111

DISCUSSION

Our study has demonstrated significant impairment in sustained attention and executive functions in young, euthymic people with bipolar disorder compared with well-matched healthy controls, even after controlling for the effects of residual depressive symptoms.

Comparison with previous studies

Our findings are largely consistent with those of previous studies (for review, see Reference Savitz, Solms and RamesarSavitz et al, 2005), including a recent study from India (Reference Goswami, Sharma and KhastigirGoswami et al, 2006). Our study differed from the latter study in that their participants were much older and had multiple episodes. In addition, soft neurological signs and social disability were also measured in that study. Our findings are complementary to those of recent studies implicating impairment not just in sustained attention but also in executive functions (Reference McKay, Tarbuck and ShapleskeMcKay et al, 1995; Reference Ferrier, Stanton and KellyFerrier et al, 1999; Martinez-Aran et al, Reference Martinez-Aran, Vieta and Colom2004a ,Reference Martinez-Aran, Vieta and Reinares b ; Reference Savitz, Solms and RamesarSavitz et al, 2005; Reference Thompson, Gallagher and HughesThompson et al, 2005). However, some earlier studies demonstrated deficits in sustained attention (Reference Ferrier, Stanton and KellyFerrier et al, 1999; Reference Clark, Iversen and GoodwinClark et al, 2002; Reference Clark and GoodwinClark & Goodwin, 2004), whereas two others did not (Reference Robertson, Kutcher and LagaceRobertson et al, 2003; Reference Goswami, Sharma and KhastigirGoswami et al, 2006).

Although our findings are similar to those of previous studies, effect sizes exceeded 1 on several of the neuropsychological variables. The effect sizes in previous studies usually ranged between 0.3 and 1 (Reference Robinson, Goswami and GallagherRobinson et al, 2004). We examined patient subgroups based on number of episodes, family history of bipolar disorder, gender and intensity of current treatment to identify whether the large effect sizes could be explained by any of these parameters. However, largely the differences were not significant. In the correlation analysis too, there was no correlation between age at onset, duration of illness and number of admissions with neuropsychological performance. None of these could explain the variations in the effect size. However, the medication status and the nature of the sample might have some bearing on the performance. The sample was recruited from a tertiary care setting, which essentially caters for severely ill patients.

Are neuropsychological deficits the result of the disease process or trait-related?

Most previous studies included people who were much older than our sample and who experienced multiple relapses with long-term exposure to psychotropic medication (Reference Savitz, Solms and RamesarSavitz et al, 2005). Our findings suggest that the deficits are possibly trait-related, considering that they were detected in young euthymic individuals with few episodes of the disorder. Cognitive deficits could be the endophenotype of mood disorders (Reference Clark, Sarna and GoodwinClark et al, 2005b ). However, it is likely that they could worsen with progression of illness. It has been shown that neuropsychological deficits in bipolar disorder correlate with both the number of affective episodes and the overall duration of illness (Reference Savitz, Solms and RamesarSavitz et al, 2005). In our study we found only modest evidence for this (Table 3). There was some indication of greater impairment with longer time spent in affective episodes. It is possible that with progression of the illness, greater correlation between neuropsychological deficits and severity of illness would be seen, as in other studies. Such associations are often considered to be indicators of a progressive disease process. However, one needs to be cautious in arriving at such conclusions because the direction of causality cannot be determined from correlational analysis. The result may well be interpreted to mean that those with neurocognitive deficits are more vulnerable to spending a greater time ill due to longer episodes and frequent relapses.

Confounding factors

Previous studies have highlighted the confounding effects of minor affective symptoms on neurocognitive performance (Reference Ferrier, Stanton and KellyFerrier et al, 1999; Reference Clark, Iversen and GoodwinClark et al, 2002). However, a majority of our participants had no mood symptoms (Table 1) and there was no correlation between neuropsychological performance and HRSD score. Our sample was also much ‘cleaner’; there was no evidence of any other Axis I disorder, including ‘lifetime’ alcohol and substance misuse.

A confounding effect of psychotropic drugs on neuropsychological performance cannot be ruled out. A majority of the patient group were taking lithium and atypical antipsychotic agents. Nearly a third of our patients were also taking trihexyphenidyl. Adverse effects of lithium (Reference Kocsis, Shaw and StokesKocsis et al, 1993; Reference Honig, Arts and PondsHonig et al, 1999), anticonvulsants (Reference Thompson and TrimbleThompson & Trimble, 1982), antipsychotics (Reference KingKing, 1994) and trihexyphenidyl (Reference Gold, Goldberg, Kleinman, Mohr and BrouwersGold et al, 1991; Reference Sweeney, Keilp and HaasSweeney et al, 1991; Reference HeinikHeinik, 1998) on cognitive functions are well documented, although there is some evidence that lithium may not cause cognitive deficits (Reference Engelsmann, Katz and GhadirianEngelsmann et al, 1988; Reference Joffe, MacDonald and KutcherJoffe et al, 1988; Reference Goswami, Gulrajani and MooreGoswami et al, 2002), and that anticonvulsants (Reference DrevetsDrevets, 2000; Reference Manji, Moore and ChenManji et al, 2000) and atypical antipsychotics (Reference Bilder, Goldman and VolavkaBilder et al, 2002) may even improve cognitive performance. The confounding effect of psychotropic medication on neuropsychological performance remains in most studies. It would be ideal to study people with bipolar disorder who were drug-naïve or not undergoing any treatment. However, this is not a possibility since it raises ethical dilemmas, and such drug-naïve patients are perhaps not representative of the actual population of people with bipolar disorder who seek help.

Limitations

The sample size was relatively small and the study was cross-sectional. We did not have any measure of premorbid IQ. Not all the tests used in the study have been validated in the Indian population, but this is unlikely to be a major limitation since the tests are routinely used in clinical services and are well validated in other populations. Moreover, the study had a matched control group. The definition of euthymia was not prospective, as in some other studies (Reference Thompson, Gallagher and HughesThompson et al, 2005; Reference Goswami, Sharma and KhastigirGoswami et al, 2006). Participants in our study were not drug-free and a significant proportion of them were taking trihexyphenidyl.

Implications for future research

Our findings demonstrate that neuropsychological deficits are possibly trait-related. The deficits in the long run can cause considerable impairment in psychosocial and occupational functioning (Martinez-Aran et al, Reference Martinez-Aran, Vieta and Colom2004a ,Reference Martinez-Aran, Vieta and Reinares b ; Reference Thompson, Gallagher and HughesThompson et al, 2005); therefore, greater emphasis should be placed on routine assessment of cognitive function in patients with bipolar disorder. Early intervention in the form of neuropsychological rehabilitation may be particularly important, as there is some evidence that these deficits may increase with disease progression. The role of available pharmacological agents in the amelioration of neurocognitive deficits needs to be systematically studied. More research on people with first-episode disorder, high-risk populations and long-term assessments are needed to elucidate further the nature of neuropsychological deficits in bipolar disorder, and whether these constitute a stable endophenotype of this condition.

Acknowledgements

The authors thank Dr B. M. Suresh and Dr T. Jagadisha of the Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, for their assistance in the recruitment of patients and helpful suggestions for the manuscript respectively.

Footnotes

Declaration of interest

None.

References

American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.Google Scholar
Bilder, R. M., Goldman, R. S., Volavka, J., et al (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 159, 10181028.CrossRefGoogle ScholarPubMed
Clark, L. & Goodwin, G. M. (2004) State- and trait-related deficits in sustained attention in bipolar disorder. European Archives of Psychiatry and Clinical Neurosciences, 254, 6168.CrossRefGoogle ScholarPubMed
Clark, L., Iversen, S. D. & Goodwin, G. M. (2002) Sustained attention deficit in bipolar disorder. British Journal of Psychiatry, 180, 313319.CrossRefGoogle ScholarPubMed
Clark, L., Kempton, M. J., Scarna, A., et al (2005a) Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biological Psychiatry, 57, 183187.CrossRefGoogle ScholarPubMed
Clark, L., Sarna, A. & Goodwin, G. M. (2005b) Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression. American Journal of Psychiatry, 162, 19801982.CrossRefGoogle Scholar
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Lawrence Erlbaum.Google Scholar
Comalli, P. E., Wapner, S. & Werner, H. (1962) Interference effects of Stroop color-word test in childhood, adulthood and aging. Journal of Genetic Psychology, 100, 4753.CrossRefGoogle ScholarPubMed
Cornblatt, B. A., Risch, N. J., Faris, G., et al (1988) The Continuous Performance Test, Identical Pairs Version (CPT-IP), I: new findings about sustained attention in normal families. Psychiatry Research, 26, 223238.CrossRefGoogle ScholarPubMed
Denicoff, K. D., Ali, S. O., Mirsky, A. F., et al (1999) Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. Journal of Affective Disorders, 56, 6773.CrossRefGoogle ScholarPubMed
Drevets, W. C. (2000) Neuroimaging studies of mood disorders. Biological Psychiatry, 48, 813829.CrossRefGoogle ScholarPubMed
Dunlop, W. P., Cortina, J. M., Vaslow, J. B., et al (1996) Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods, 1, 170177.CrossRefGoogle Scholar
Engelsmann, F., Katz, J., Ghadirian, A. M., et al (1988) Lithium and memory: along-term follow-up study. Journal of Clinical Psychopharmacology, 8, 207212.CrossRefGoogle Scholar
Ferrier, I. N., Stanton, B. R., Kelly, T. P., et al (1999) Neuropsychological function in euthymic patients with bipolar disorder. British Journal of Psychiatry, 175, 246251.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975) ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 196198.Google Scholar
Gold, J. M., Goldberg, T. E., Kleinman, J. E., et al (1991) The impact of symptomatic state and pharmacological treatment on cognitive functioning of patients with schizophrenia and mood disorders. In Handbook of Clinical Trials: The Neurobehavioral Approach. (eds Mohr, E. & Brouwers, P.), pp. 185214. Lisse: Swets & Zeitlinger.Google Scholar
Goswami, U., Gulrajani, C., Moore, P. B., et al (2002) Neurocognitive decline in bipolar mood disorder: role of mood stabilizers. Journal of Psychopharmacology, 16, A45.Google Scholar
Goswami, U., Sharma, A., Khastigir, U., et al (2006) Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. British Journal of Psychiatry, 188, 366373.CrossRefGoogle ScholarPubMed
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.CrossRefGoogle ScholarPubMed
Heaton, R. K., Chelune, G. J., Talley, J. L., et al (1993) Wisconsin Card Sorting Test Manual. Revised and Expanded. Odessa, FL: Psychological Assessment Resources.Google Scholar
Heinik, J. (1998) Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia. International Psychogeriatrics, 10, 103108.CrossRefGoogle ScholarPubMed
Honig, A., Arts, B. M., Ponds, R. W., et al (1999) Lithium induced cognitive side effects in bipolar disorder: a qualitative analysis and implications for daily practice. International Journal of Clinical Psychopharmacology, 14, 167171.Google ScholarPubMed
Joffe, R. T., MacDonald, C. & Kutcher, S. P. (1988) Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. Journal of Clinical Psychopharmacology, 8, 425428.CrossRefGoogle ScholarPubMed
King, D. J. (1994) Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatrica Scandinavica Supplementum, 380, 5358.CrossRefGoogle ScholarPubMed
Kocsis, J. H., Shaw, E. D., Stokes, P. E., et al (1993) Neuropsychologic effects of lithium discontinuation. Journal of Clinical Psychopharmacology, 13, 268275.CrossRefGoogle ScholarPubMed
Lezak, M. D. (1995) Neuropsychological Assessment (3rd edn). New York: Oxford University Press.Google Scholar
Manji, H. K., Moore, G. J. & Chen, G. (2000) Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biological Psychiatry, 48, 740754.CrossRefGoogle ScholarPubMed
Martinez-Aran, A., Vieta, E., Colom, F., et al (2004a) Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disorders, 6, 224232.CrossRefGoogle ScholarPubMed
Martinez-Aran, A., Vieta, E., Reinares, M., et al (2004b) Cognitive function across manic or hypomanic, depressed and euthymic states in bipolar disorder. American Journal of Psychiatry, 161, 262270.CrossRefGoogle ScholarPubMed
McGuffin, P., Farmer, A. & Harvey, I. (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764770.CrossRefGoogle ScholarPubMed
McKay, A. P., Tarbuck, A. F., Shapleske, J., et al (1995) Neuropsychological function in manic-depressive psychosis: evidence for persistent deficits in patients with chronic, severe illness. British Journal of Psychiatry, 167, 5157.CrossRefGoogle ScholarPubMed
Mukundan, C. R. (1996) NIMHANS neuropsychological battery: test descriptions, instructions, clinical data and interpretation. In Proceedings of the National Workshop in Clinical Neuropsychology: 24–29 October 1996, NIMHANS, Bangalore, India. Bangalore: NIMHANS Publications.Google Scholar
Oldfield, R. C. (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia, 9, 97113.CrossRefGoogle ScholarPubMed
Rao, S. L., Subbakrishna, D. K. & Gopukumar, K. (2004) NIMHANS Neuropsychology Battery – 2004. Bangalore: NIMHANS Publications.Google Scholar
Reitan, R. M. & Wolfson, D. (1985) The Halstead–Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press.Google Scholar
Robertson, H. A., Kutcher, S. P. & Lagace, D. C. (2003) No evidence of attentional deficits in stabilized bipolar youth relative to unipolar and control comparators. Bipolar Disorders, 5, 330339.CrossRefGoogle ScholarPubMed
Robinson, L., Goswami, U., Gallagher, P., et al (2004) Cognitive deficits in bipolar subjects: Delhi and UK data. Acta Psychiatrica Scandinavica Supplementum, 423, 3334.Google Scholar
Savitz, J., Solms, M. & Ramesar, R. (2005) Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disorders, 7, 216235.CrossRefGoogle ScholarPubMed
Shallice, T. (1982) Specific impairments of planning. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, 298, 199209.Google ScholarPubMed
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., et al (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM–IV and ICD-10. Journal of Clinical Psychiatry, 59 (suppl. 20), 2257.Google ScholarPubMed
Spreen, O. & Strauss, J. (1998) A Compendium of Neuropsychological Tests: Administration, Norms and Commentary (2nd edn). New York: Oxford University Press.Google Scholar
Sweeney, J. A., Keilp, J. G., Haas, G. L., et al (1991) Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297308.CrossRefGoogle ScholarPubMed
Thompson, P. J. & Trimble, M. R. (1982) Anticonvulsant drugs and cognitive functions. Epilepsia, 23, 531544.CrossRefGoogle ScholarPubMed
Thompson, J. M., Gallagher, P., Hughes, J. H., et al (2005) Neurocognitive impairment in euthymic patients with bipolar affective disorder. British Journal of Psychiatry, 186, 3240.CrossRefGoogle ScholarPubMed
Williams, J., Farmer, A. E., Archenneil, M., et al (1996) A multi-centre inter-rater reliability study using the OPCRIT computerised diagnostic system. Psychological Medicine, 26, 775783.CrossRefGoogle Scholar
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429435.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Demographic and clinical characteristics of the sample

Figure 1

Table 2 Neuropsychological performance

Figure 2

Table 3 Correlation (Spearmans's rho) of illness characteristics and neurocognitive performance in patients with bipolar disorder.

Submit a response

eLetters

No eLetters have been published for this article.